2020
DOI: 10.1159/000512322
|View full text |Cite
|
Sign up to set email alerts
|

Multiple Microbleeds: A Serious Neurological Manifestation in a Critically Ill COVID-19 Patient

Abstract: Coronavirus disease 2019 (COVID-19) is a viral illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is worldwide emerging evidence of multisystem involvement including different neurological manifestations in COVID-19 patients. As a result, healthcare systems worldwide are not only experiencing diagnostic but also therapeutic and prognostic challenges with COVID-19-related complications. Cerebral microbleeds and leukoencephalopathy have been described in COVID-19 pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 10 publications
0
8
0
Order By: Relevance
“… 37 - 39 In humans, COVID-19-associated brain pathologies, such as encephalitis, cerebral microbleeds, stroke, and diffuse leukoencephalopathy are described, and it is hypothesized that inflammation of blood vessels secondary to virus binding of endothelium (rich in ACE2) results in subsequent breaks and leaks. 37 , 38 Another potential route for viral entry into the brain following intranasal inoculation could be through the olfactory nerve that provides a pathway between the olfactory bulb, located near the nasal cavity, and the brain; however, a recent review suggests a weak case for infection through this route. 40 There are little data on SARS-CoV-2-related encephalitis in nonhuman primates.…”
Section: Discussionmentioning
confidence: 99%
“… 37 - 39 In humans, COVID-19-associated brain pathologies, such as encephalitis, cerebral microbleeds, stroke, and diffuse leukoencephalopathy are described, and it is hypothesized that inflammation of blood vessels secondary to virus binding of endothelium (rich in ACE2) results in subsequent breaks and leaks. 37 , 38 Another potential route for viral entry into the brain following intranasal inoculation could be through the olfactory nerve that provides a pathway between the olfactory bulb, located near the nasal cavity, and the brain; however, a recent review suggests a weak case for infection through this route. 40 There are little data on SARS-CoV-2-related encephalitis in nonhuman primates.…”
Section: Discussionmentioning
confidence: 99%
“… 49 y/o Acute No No n/a MRI sequence: FLAIR, DWI, ADC, SWAN No large vessel occlusion; 2 small cortical acute ischemic lesions in pre and postcentral gyrus. ( Haroon et. al., 2020 ) Case-report COVID-19 positive patient admitted to ICU.…”
Section: Resultsmentioning
confidence: 99%
“…Twenty-nine case reports were included detailing patients with COVID-19-induced cerebromicrovascular complications with neuroimaging indicative of MB and/or small vessel ischemic lesions or infarctions ( Table 1 ). Eighteen out of twenty-nine case reports presented patients who were admitted to the ICU due to respiratory failure/distress and required one or more of the following: intubation, mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) ( Ahmed et al, 2022 , Backman et al, 2022 , Cannac et al, 2020 , De Stefano et al, 2020 , Elshereye and Erdinc, 2020 , Gupta et al, 2020 , Hanafi et al, 2020 , Haroon et al, 2020 , Neppala et al, 2021 , Petersson et al, 2022 , Planinc et al, 2020 , Reichard et al, 2020 , Rudilosso et al, 2020 , Shoskes et al, 2020 , Toeback et al, 2021 , Tristán-Samaniego et al, 2022 , Vattoth et al, 2020 , Witvoet et al, 2021 ). MB were seen in 17/29 case reports ( Backman et al, 2022 , Cannac et al, 2020 , De Stefano et al, 2020 , Finsterer, 2022 , Fraiman et al, 2020 , Gupta et al, 2020 , Hanafi et al, 2020 , Haroon et al, 2020 , Liang et al, 2021 , Petersson et al, 2022 , Planinc et al, 2020 , Reichard et al, 2020 , Rudilosso et al, 2020 , Shoskes et al, 2020 , Toeback et al, 2021 , Tristán-Samaniego et al, 2022 , Vattoth et al, 2020 , Witvoet et al, 2021 ) with 14/17 being in patients with severe pulmonary/respiratory complications.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations